Source: EURLEX
Language: en
Format: md

[**Avis juridique important**](../../../editorial/legal_notice.htm)

*|*

# 91999E1005

**WRITTEN QUESTION No. 1005/99 by Ian HUDGHTON Research into synthetic and plant-derived hormones** 
  
*Official Journal C 370 , 21/12/1999 P. 0152*

  

WRITTEN QUESTION E-1005/99

by Ian Hudghton (V) to the Commission

(20 April 1999)

Subject: Research into synthetic and plant-derived hormones

Given the animal welfare controversy surrounding production of the hormone replacement therapy drug Premarin, can the Commission indicate if the EU currently funds research into the production of alternative synthetic and plant-derived hormones and whether there are plans to increase such funding?

Answer given by Mrs Cresson on behalf of the Commission

(7 May 1999)

The Commission is currently funding research on the safety aspects of post-menopausal therapy but not research into the production of alternative synthetic and plant-derived hormones.

In the fifth framework programme for research and technical development (1998-2002), it is foreseen to support research on the development of new therapeutic substances, including recombinant synthetic therapies and hormones which are specifically mentioned in the working programme under key action "Cell factory", bullet point 3.1: "New and innovative health related processes & products".

[Top](#document1)